Skip to main content

Annovis Bio's stock takes a ride following positive study results for experimental Parkinson's therapy

The new drug candidate improved motor function in a small group of patients with the neurological disorder.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.